Skip to main content
. 2022 Nov 24;23(4):61–72. doi: 10.1038/s41397-022-00297-1

Fig. 5. Affects of compounds (i.e., instances) on the PPARA pathway activity and expression pattern.

Fig. 5

a The PPARA pathway activity score difference of the 1390 CMAP gene expressoin instances. The y-axis shows the difference between the activity score in the treatment and the paired control for each instance. The x-axis shows the instances ordered by decreasing corresponding activity score difference. b The connectivity score of the 1390 CMAP gene expression instances. The y-axis shows the connectivity score and the x-axis shows the instances ordered by increasing corresponding connectivity score. c A Venn diagram showing the intersection between the top 50 drugs identified by the activity score difference and the activity score.